Commercial Advisory Group
Helping you navigate complexity with confidence
Success in today’s life sciences commercial market environment demands that biopharma companies establish and demonstrate asset value early in the development lifecycle.
With an unmatched legacy in strategic launches, our Consulting team’s industry expertise and predictive business intelligence approach offers insights that ensure optimal market positioning, recalibrating strategies in response to market shifts, and enhancing decision-decision-making.
Answering critical business questions for a successful commercialization plan
Where and how should we invest for long-term profitability?
With our extensive experience in portfolio evaluation and therapeutic area strategy development for both early-stage biotech and mid-to-large pharma customers, we help you assess growth opportunities, business model options and investment decisions.
By combining the capabilities of a consulting firm with broad clinical, medical affairs and commercialization expertise, we access product development insights and know-how to help inform your strategy.
Capabilities include:
- Corporate visioning
- Long-range planning
- Therapeutic area strategy
- Asset search
- Diligence
- Pharma product licensing & valuation
- Healthcare commercialization models
How should we prepare our pharma asset and organization to commercialize successfully?
Rapid change across the healthcare landscape means that traditional go-to-market models are no longer fully fit-for-purpose. With extensive pharma commercialization consulting expertise, we bring a disciplined approach to helping you commercialize your brands and formulate and evaluate viable strategic choices to best prepare your unique asset and organization to maximize their full potential.
We combine science with commercial planning (e.g., marketing, market access, sales, medical) to bring deep functional and therapeutic area insights to inform strategy, planning, and implementation. Using our strategic framework and Launch Playbook® and experience with over 500 launch engagements for both established and emerging biopharma companies, we help our customers assess their systems, processes and capabilities for long term success.
Capabilities include:
- Biopharma product development strategy
- Indication strategy: prioritization and sequencing
- Patient journey mapping
- Customer segmentation
- GTM strategy
- Launch and commercial excellence
- Healthcare brand planning
- Lifecycle management
- Growth strategy
How do we cultivate unparalleled customer experience with the brand and organization?
A complex, interconnected web of customers as well as the patient’s role as owners of their care have created new dynamics for customer engagement. We blend our unique capabilities to increase customer intimacy, flexibility and efficiency with processes that combine precision targeting, customer journeys, advanced content, integrated delivery and analytics.
We use a combination of proven analysis methodologies coupled with customer insights and therapeutic expertise to provide you with actionable recommendations for enhancing customer and digital engagement.
The benefit comes in the form of more efficient investment and improved sales force performance with insights that can inform sales force decision making such as how to scale, and the ideal type of face-to-face engagement. Additionally, customer profiling and planning and healthcare omnichannel engagement strategies can be powered to resonate with a broader set of customers. Improved performance shows up through improved field team coordination thanks to more efficient customer targeting, messaging and routing.
Capabilities include:
- Customer and account segmentation & prioritization
- Customer engagement strategies
- Digital road maps
- Omnichannel marketing
- Local market strategy
See what our Commercial Advisory Group can do for you.
Related Content
Looking for exclusive insight?
